Page last updated: 2024-09-03

24-hydroxycholesterol and Neuroendocrine Tumors

24-hydroxycholesterol has been researched along with Neuroendocrine Tumors in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bachi, A; Bernardi, R; Bordignon, C; Coltella, N; Corna, G; Crocchiolo, R; Doglioni, C; Gustafsson, JÅ; Invernizzi, F; Lin, CY; Maggioni, D; Moresco, M; Raccosta, L; Restuccia, U; Russo, V; Soncini, M; Traversari, C1

Other Studies

1 other study(ies) available for 24-hydroxycholesterol and Neuroendocrine Tumors

ArticleYear
24-Hydroxycholesterol participates in pancreatic neuroendocrine tumor development.
    Proceedings of the National Academy of Sciences of the United States of America, 2016, 10-11, Volume: 113, Issue:41

    Topics: Animals; Cell Transformation, Neoplastic; Cholestanetriol 26-Monooxygenase; Cholesterol 24-Hydroxylase; Cytokines; Disease Models, Animal; Disease Progression; Enzyme Activation; Female; Fluorescent Antibody Technique; Gene Expression; Gene Expression Regulation, Neoplastic; GTPase-Activating Proteins; Hydroxycholesterols; Hypoxia-Inducible Factor 1, alpha Subunit; Immunohistochemistry; Male; Mice; Mice, Transgenic; Neovascularization, Pathologic; Neuroendocrine Tumors; Pancreatic Neoplasms; Vascular Endothelial Growth Factor A

2016